dipyridamole has been researched along with Friedreich Disease in 1 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
| Excerpt | Relevance | Reference |
|---|---|---|
| " After dosing with dipyridamole-201 thallium, we found: a completely reversible perfusion defect in the apical and a partially reversible defect in the posterolateral wall of the left ventricle in 1 case; a partially reversible perfusion defect in the anterior and posterior walls of the left ventricle in 1 case; and a persistent anterolateral perfusion defect in 1 case." | 1.28 | Myocardial perfusion in Friedreich's ataxia: assessment by dipyridamole thallium-201 imaging. ( Casazza, F; Morpurgo, M; Palagi, B; Picozzi, R, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Casazza, F | 1 |
| Palagi, B | 1 |
| Picozzi, R | 1 |
| Morpurgo, M | 1 |
1 other study available for dipyridamole and Friedreich Disease
| Article | Year |
|---|---|
Myocardial perfusion in Friedreich's ataxia: assessment by dipyridamole thallium-201 imaging.
Topics: Adolescent; Adult; Dipyridamole; Echocardiography; Female; Friedreich Ataxia; Heart; Heart Diseases; | 1991 |